- Stéphanie Gonvers, Parissa Tabrizian, Emmanuel Melloul, Olivier Dormond, Myron Schwartz, Nicolas Demartines, Ismail Labgaa. Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?. Front. Oncol. 2022;12
- Sheng-Jun Xu, Qiang Wei, Xin Hu, Chang-Biao Li, Zhe Yang, Shu-Sen Zheng, Xiao Xu. No-touch recipient hepatectomy in liver transplantation for liver malignancies: A state-of-the-art review. Hepatobiliary & Pancreatic Diseases International 2024
- Marina Berenguer, Eleonora de Martin, Amelia J. Hessheimer, Josh Levitsky, Daniel G. Maluf, Valeria R. Mas, Nazia Selzner, Helena Hernàndez-Èvole, Alina Lutu, Nabeel Wahid, Haseeb Zubair. European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation. Transpl Int 2023;36
- Zheyu Zhou, Qiaoyu Liu, Jinsong Liu, Wenwen Li, Shuya Cao, Jiawei Xu, Jun Chen, Xiaoliang Xu, Chaobo Chen. Research progress of protein induced by vitamin K absence or antagonist II in liver transplantation for hepatocellular carcinoma. Heliyon 2024;10:e30622
- Hao Liu, Vrishketan Sethi, Xingjie Li, Yao Xiao, Abhinav Humar. Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future. Semin Liver Dis 2024;44:079
- Zhao-Shan Niu, Wen-Hong Wang, Xiao-Jun Niu. Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World J Gastroenterol 2022;28:6433
- Zhengrong Ou, Shoushuo Fu, Jian Yi, Jingxuan Huang, Weidong Zhu. Diagnostic value of expressions of cancer stem cell markers for adverse outcomes of hepatocellular carcinoma and their associations with prognosis: A Bayesian network meta‑analysis. Oncol Lett 2024;28
- Yeochan Yun, Seewoo Kim, Sang-Nam Lee, Hyeon-Yeol Cho, Jeong-Woo Choi. Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy. Nano Convergence 2024;11
- Takuto Nosaka, Yosuke Murata, Yu Akazawa, Kazuto Takahashi, Tatsushi Naito, Hidetaka Matsuda, Masahiro Ohtani, Yasunari Nakamoto. Changes of circulating tumor cells expressing CD90 and EpCAM in early-phase of atezolizumab and bevacizumab for hepatocellular carcinoma. Heliyon 2024;10:e34441